Valente ST - Search Results

1

In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment.

Kessing CF, Nixon CC, Li C, Tsai P, Takata H, Mousseau G, Ho PT, Honeycutt JB, Fallahi M, Trautmann L, Garcia JV, Valente ST. Kessing CF, et al. Among authors: valente st. Cell Rep. 2017 Oct 17;21(3):600-611. doi: 10.1016/j.celrep.2017.09.080. Cell Rep. 2017. PMID: 29045830 Free PMC article.

2

An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription.

Mousseau G, Clementz MA, Bakeman WN, Nagarsheth N, Cameron M, Shi J, Baran P, Fromentin R, Chomont N, Valente ST. Mousseau G, et al. Among authors: valente st. Cell Host Microbe. 2012 Jul 19;12(1):97-108. doi: 10.1016/j.chom.2012.05.016. Cell Host Microbe. 2012. PMID: 22817991 Free PMC article.

3

Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.

Mousseau G, Valente S. Mousseau G, et al. Biology (Basel). 2012 Nov 19;1(3):668-97. doi: 10.3390/biology1030668. Biology (Basel). 2012. PMID: 24832514 Free PMC article.

4

Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice.

Mediouni S, Jablonski J, Paris JJ, Clementz MA, Thenin-Houssier S, McLaughlin JP, Valente ST. Mediouni S, et al. Among authors: valente st. Curr HIV Res. 2015;13(1):64-79. doi: 10.2174/1570162x13666150121111548. Curr HIV Res. 2015. PMID: 25613133 Free PMC article.

5

Targeting HIV transcription: the quest for a functional cure.

Mousseau G, Mediouni S, Valente ST. Mousseau G, et al. Among authors: valente st. Curr Top Microbiol Immunol. 2015;389:121-45. doi: 10.1007/82_2015_435. Curr Top Microbiol Immunol. 2015. PMID: 25731772 Free PMC article. Review.

6

The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.

Mousseau G, Kessing CF, Fromentin R, Trautmann L, Chomont N, Valente ST. Mousseau G, et al. Among authors: valente st. mBio. 2015 Jul 7;6(4):e00465. doi: 10.1128/mBio.00465-15. mBio. 2015. PMID: 26152583 Free PMC article.

7

Didehydro-Cortistatin A: a new player in HIV-therapy?

Mousseau G, Valente ST. Mousseau G, et al. Among authors: valente st. Expert Rev Anti Infect Ther. 2016;14(2):145-8. doi: 10.1586/14787210.2016.1122525. Epub 2015 Dec 11. Expert Rev Anti Infect Ther. 2016. PMID: 26581953 Free PMC article.

8

Cell-Permeable Peptides Containing Cycloalanine Residues.

Wu H, Mousseau G, Mediouni S, Valente ST, Kodadek T. Wu H, et al. Among authors: valente st. Angew Chem Int Ed Engl. 2016 Oct 4;55(41):12637-42. doi: 10.1002/anie.201605745. Epub 2016 Aug 16. Angew Chem Int Ed Engl. 2016. PMID: 27529332 Free PMC article.

9

Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.

Mousseau G, Valente ST. Mousseau G, et al. Among authors: valente st. Curr Pharm Des. 2017;23(28):4079-4090. doi: 10.2174/1381612823666170622104355. Curr Pharm Des. 2017. PMID: 28641539 Free PMC article. Review.

10

Potent suppression of HIV-1 cell attachment by Kudzu root extract.

Mediouni S, Jablonski JA, Tsuda S, Richard A, Kessing C, Andrade MV, Biswas A, Even Y, Tellinghuisen T, Choe H, Cameron M, Stevenson M, Valente ST. Mediouni S, et al. Among authors: valente st. Retrovirology. 2018 Sep 20;15(1):64. doi: 10.1186/s12977-018-0446-x. Retrovirology. 2018. PMID: 30236131 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters